UNICLONE
Dead / Cancelled — Cancelled — Section 8 (as of 09 May 2014)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 78131079
- Registration number
- 2771609
- Mark type
- Word mark
- Filed
- 24 May 2002
- Published for opposition
- 15 Jul 2003
- Registered
- 07 Oct 2003
- Attorney of record
- Jennifer Fraser
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and veterinarian preparations containing therapeutic proteins, therapeutic nucleicacids, gene and/or cells for health and medical care, namely, for the treatment of allergies, arthritis, cancer, diabetes, diseases of the central nervous system, inflammatory diseases, metabolic disorders, viral diseases; pharmaceutical preparations for use in cardiology and oncology; medical and pharmaceutical products, namely human vaccines, anti-infectives, diagnostic proteins, therapeutic proteins, therapeutic nucleicacids, gene and/or cells; medical, biotechnological and gene-technological products and preparations obtainable by protein-expression-banks and nucleicacid-banks together with expression-vectors, proteomics, proteome-analysis, biochips, comprising proteins and nucleicacids, protein-biochips, arrays for use in or at human beings or animals, namely, proteins; diagnostics and detergents for medical and veterinarian use, namely diagnostic preparations and reagents for clinical or medical laboratory use
- Class 009 — Scientific and electric apparatus: Scientific devices and instruments for the protein-expression in a protein-expression bank, namely, protein-biochips, comprising clones for identification and validation of proteins and encoding nucleicacids together with expression-vectors thereof
- Class 042 — Scientific and technological services: Services for chemical, pharmaceutical, biotechnological, diagnostical, analytical, gene-technological, medical laboratories or industrial facilities or research- and development facilities, namely consulting and analysis in the field of chemistry, pharmacy, biotechnology, diagnostic, analytical, gene-technology, bio-informatics, target validation and drug development, by means of nucleicacid- or protein-biochips, protein-expression-banks, nucleicacid-banks, polypeptide or nucleicacid-libraries and arrays, automation, application and use of protein-biochips; consulting and analysis in the field of automation, application and use of proteomics, proteome studies, proteome designs, peptide and protein analytic and identification, purification and characterization, 1 D and 2D gele electrophorese, mass spectrometry, robotics for proteomics and protein-expression-banks
Owner
- Protagen AG, Bochum, DE
- Protagen AG, Bochum, DE
- Protagen AG, Bochum, DE
Prosecution history
- 09 May 2014 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 22 Oct 2009 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 22 Oct 2009 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 07 Oct 2009 — TEAS SECTION 8 & 15 RECEIVED
- 07 Oct 2009 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 07 Oct 2009 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 18 Jul 2008 — CASE FILE IN TICRS
- 07 Oct 2003 — REGISTERED-PRINCIPAL REGISTER
- 15 Jul 2003 — PUBLISHED FOR OPPOSITION
- 25 Jun 2003 — NOTICE OF PUBLICATION
- 24 Apr 2003 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Mar 2003 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 21 Mar 2003 — PAPER RECEIVED
- 08 Jan 2003 — NON-FINAL ACTION E-MAILED
- 11 Oct 2002 — ASSIGNED TO EXAMINER